Safety and Effectiveness of Chemoembolization with Drug-Eluting Beads for Advanced-Stage Hepatocellular Carcinoma

[1] Parkin DM(2005)Global cancer statistics, 2002 CA Cancer J Clin 55 74-108

[2] Bray F(2003)Hepatocellular carcinoma Curr Opin Gastroenterol 19 243-249

[3] Ferlay J(2010)Current strategy for staging and treatment: the BCLC update and future prospects Semin Liver Dis 30 61-74

[4] Pisani P(2005)Updated treatment approach to hepatocellular carcinoma J Gastroenterol 40 225-235

[5] Marrero JA(2005)Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma Hepatology 42 1208-1236

[6] Forner A(2011)American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update Hepatology 53 1020-1022

[7] Reig ME(2010)Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study Cardiovasc Intervent Radiol 33 41-52

[8] de Lope CR(2008)Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 378-390

[9] Bruix J(2009)Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study Lancet Oncol 10 794-800

[10] Llovet JM(2002)Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 1734-1739

[1] Parkin DM(2005)Global cancer statistics, 2002 CA Cancer J Clin 55 74-108

[2] Bray F(2003)Hepatocellular carcinoma Curr Opin Gastroenterol 19 243-249

[3] Ferlay J(2010)Current strategy for staging and treatment: the BCLC update and future prospects Semin Liver Dis 30 61-74

[4] Pisani P(2005)Updated treatment approach to hepatocellular carcinoma J Gastroenterol 40 225-235

[5] Marrero JA(2005)Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma Hepatology 42 1208-1236

[6] Forner A(2011)American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update Hepatology 53 1020-1022

[7] Reig ME(2010)Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study Cardiovasc Intervent Radiol 33 41-52

[8] de Lope CR(2008)Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 378-390

[9] Bruix J(2009)Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study Lancet Oncol 10 794-800

[10] Llovet JM(2002)Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 1734-1739